Hugo is the first UK baby born after a womb transplant from a deceased donor.

Hugo Powell is the first child in the UK born to a mother who received a womb from a deceased donor; he was delivered in December at Queen Charlotte's and Chelsea Hospital and his mother, Grace Bell, was born with MRKH.

A baby boy named Hugo Powell was delivered in December at Queen Charlotte's and Chelsea Hospital in London. His mother, Grace Bell, was born with Mayer-Rokitansky-Kuster-Hauser (MRKH), a condition resulting in an underdeveloped or absent womb. The womb used in her transplant came from a deceased donor, and this birth is reported as the first in the UK using a womb from a deceased donor. The transplant operation was carried out in 2024 and the family and clinical team have described the occasion as emotionally significant. What we know: - Hugo Powell was born weighing 6lb 13oz (3.1kg) by Caesarean section at Queen Charlotte's and Chelsea Hospital in December. - Grace Bell, the mother, was born with MRKH and underwent a seven-hour womb transplant carried out by Isabel Quiroga at the Oxford Transplant Centre in 2024, followed by fertility treatment at The Lister Fertility Clinic. - The womb came from a deceased donor; five other organs from the same donor were transplanted into four people. - The report says this is the first UK birth from a deceased-womb donation; about 25 to 30 babies have been born worldwide from deceased-womb donation and most womb transplants overall involve living donors. - Womb Transplant UK has performed and funded five womb transplants in the UK so far — two from living donors and three from deceased donors — with two babies born and three transplant recipients undergoing IVF. Summary: The birth marks a reported milestone in the UK transplant and fertility programmes and highlights the role of donation decisions made by donor families. The parents have said they may attempt a second pregnancy, after which surgeons plan to remove the transplanted womb because leaving it would require lifelong immunosuppressant drugs and associated risks.